DK2148670T3 - Titrering af tapentadol - Google Patents

Titrering af tapentadol

Info

Publication number
DK2148670T3
DK2148670T3 DK08749016.5T DK08749016T DK2148670T3 DK 2148670 T3 DK2148670 T3 DK 2148670T3 DK 08749016 T DK08749016 T DK 08749016T DK 2148670 T3 DK2148670 T3 DK 2148670T3
Authority
DK
Denmark
Prior art keywords
tapentadol
titration
administration
unitbcontaining
unitacontaining
Prior art date
Application number
DK08749016.5T
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2148670(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK2148670T3 publication Critical patent/DK2148670T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
DK08749016.5T 2007-04-23 2008-04-21 Titrering af tapentadol DK2148670T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (1)

Publication Number Publication Date
DK2148670T3 true DK2148670T3 (da) 2012-03-12

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08749016.5T DK2148670T3 (da) 2007-04-23 2008-04-21 Titrering af tapentadol

Country Status (22)

Country Link
US (4) US20090012180A1 (da)
EP (5) EP1985292A1 (da)
JP (4) JP5933176B2 (da)
KR (3) KR20150027840A (da)
CN (1) CN101730530B (da)
AT (1) ATE534378T1 (da)
AU (1) AU2008241013B2 (da)
CA (1) CA2683786C (da)
CY (1) CY1112320T1 (da)
DK (1) DK2148670T3 (da)
ES (1) ES2378255T3 (da)
HK (1) HK1140940A1 (da)
HR (1) HRP20120147T1 (da)
IL (1) IL201479A (da)
MX (1) MX2009011444A (da)
NZ (1) NZ580415A (da)
PL (1) PL2148670T3 (da)
PT (1) PT2148670E (da)
RU (1) RU2472497C2 (da)
SI (1) SI2148670T1 (da)
WO (1) WO2008128740A1 (da)
ZA (1) ZA200907355B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
AU2009340504A1 (en) * 2008-10-30 2010-08-26 Grunenthal Gmbh Novel and potent tapentadol dosage forms
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2566461A2 (de) * 2010-05-05 2013-03-13 Ratiopharm GmbH Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
JP5856613B2 (ja) * 2010-06-30 2016-02-10 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 過敏性腸症候群の治療において使用するためのタペンタドール
MX341072B (es) * 2010-07-23 2016-08-05 Grünenthal Gmbh * Sales o co-cristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-f enol.
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
PL3287123T3 (pl) 2011-03-04 2020-11-02 Grünenthal GmbH Wodny preparat farmaceutyczny tapentadolu do podawania doustnego
EP2680834B1 (en) 2011-03-04 2017-10-18 Grünenthal GmbH Semisolid aqueous pharmaceutical composition containing tapentadol
SI2680833T1 (sl) * 2011-03-04 2016-06-30 Gruenenthal Gmbh Parenteralno dajanje tapentadola
ES2761334T3 (es) * 2011-04-05 2020-05-19 Gruenenthal Gmbh Tapentadol para uso en el tratamiento del dolor asociado con la neuralgia del trigémino
WO2012136349A1 (en) 2011-04-05 2012-10-11 Grünenthal GmbH Tapentadol for preventing chronification of pain
RS56523B1 (sr) 2011-04-29 2018-02-28 Gruenenthal Gmbh Tapentadol za sprečavanje i lečenje depresije i anksioznosti
CA2901802C (en) * 2013-03-15 2021-03-02 Mallinckrodt Llc Abuse deterrent solid dosage form for immediate release with functional score
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
PT3273953T (pt) 2015-03-27 2019-04-01 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
CN107660147B (zh) * 2015-05-26 2021-04-30 抗菌技术生物技术研究与发展股份有限公司 用于治疗帕金森病和相关障碍的组合物
WO2017148595A1 (en) * 2016-02-29 2017-09-08 Grünenthal GmbH Titration of cebranopadol
WO2018055070A1 (en) 2016-09-23 2018-03-29 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
EP4121013A1 (en) 2020-03-16 2023-01-25 Grünenthal GmbH Scored tablet
JP2024510484A (ja) * 2021-03-17 2024-03-07 アクテリオン ファーマシューティカルズ リミテッド 製剤投与システム
EP4333820A1 (en) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
WO2004054553A1 (en) * 2002-12-13 2004-07-01 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia
US7413749B2 (en) 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
JP2016128468A (ja) 2016-07-14
EP3143993A1 (en) 2017-03-22
JP5933176B2 (ja) 2016-06-08
IL201479A0 (en) 2010-05-31
KR20180004839A (ko) 2018-01-12
CN101730530B (zh) 2013-10-23
RU2009142940A (ru) 2011-05-27
HK1140940A1 (en) 2010-10-29
CA2683786A1 (en) 2008-10-30
WO2008128740A1 (en) 2008-10-30
HRP20120147T1 (hr) 2012-03-31
US20090012180A1 (en) 2009-01-08
JP2018030864A (ja) 2018-03-01
RU2472497C2 (ru) 2013-01-20
KR20150027840A (ko) 2015-03-12
PL2148670T3 (pl) 2012-04-30
CN101730530A (zh) 2010-06-09
EP1985292A1 (en) 2008-10-29
MX2009011444A (es) 2009-11-05
US20190290603A1 (en) 2019-09-26
PT2148670E (pt) 2012-01-24
EP2422778A1 (en) 2012-02-29
ES2378255T3 (es) 2012-04-10
EP2148670B1 (en) 2011-11-23
KR102078999B1 (ko) 2020-02-19
JP2010531296A (ja) 2010-09-24
US20170079938A1 (en) 2017-03-23
SI2148670T1 (sl) 2012-03-30
CY1112320T1 (el) 2015-12-09
KR20100017267A (ko) 2010-02-16
NZ580415A (en) 2012-04-27
WO2008128740A8 (en) 2010-06-17
EP3603630A1 (en) 2020-02-05
ATE534378T1 (de) 2011-12-15
CA2683786C (en) 2021-10-26
AU2008241013B2 (en) 2013-06-20
US11344512B2 (en) 2022-05-31
EP2148670A1 (en) 2010-02-03
AU2008241013A1 (en) 2008-10-30
ZA200907355B (en) 2010-08-25
IL201479A (en) 2016-04-21
US20160074342A1 (en) 2016-03-17
JP2019131598A (ja) 2019-08-08

Similar Documents

Publication Publication Date Title
DK2148670T3 (da) Titrering af tapentadol
CY1122687T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
CY1112067T1 (el) Χρηση φλιμπανσερινης για την θεραπεια διαταραχων προ-εμμηνοπαυσιακης σεξουαλικης επιθυμιας
UA115122C2 (uk) Cd3-зв'язувальна молекула, здатна до зв'язування з cd3 людини і cd3, що не є людським
MX356210B (es) Formulaciones de polimero acrilico.
NO20084368L (no) Stabile emulsjonsformuleringer
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
EA200801997A1 (ru) Новые соединения
EA201100255A1 (ru) 5-алкинилпиримидины
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
EA201171043A1 (ru) Композиции и способы длительной терапии с применением аминопиридинов
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
CR20110552A (es) Tratamiento de transtornos resistentes a la insulina
BR112012007888A2 (pt) "métodos de tratamento usando anticorpos anti-ldl oxidada".
CL2015001180A1 (es) Combinacion farmaceutica que comprende un copolimero de carboximetilcelulosa sodica con un grado de sustitucion de 0,35 a 0,80 y gosipol o un medicamento para el tratamiento de trastornos cognitivos seleccionado de neurolepticos, antidepresivos, anticonvulsivos o una combinacion de los mismos.
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
EA200970816A1 (ru) Новая лекарственная форма
BRPI0820210A2 (pt) composto, composição farmacêutica, uso de um composto, e, método de tratamento terapêutico de um mamífero.
EA200900923A1 (ru) Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний